Rigel's Fostamatinib Being Studied by National Institute of Health in Patients with Sickle Cell Disease
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the first patient has been enrolled in a Phase 1 study evaluating ...
GlobalData on MSN4d
Rigel enrols first subject in Phase I sickle cell disease therapy trial
Rigel Pharmaceuticals has enrolled the first subject in a Phase I trial of its oral spleen tyrosine kinase (SYK) inhibitor, ...
Rigel Pharmaceuticals enrolls first patient in Phase 1 study of fostamatinib
Rigel Pharmaceuticals (RIGL) announced the first patient has been enrolled in a Phase 1 study evaluating the safety and tolerability of ...
Syndax Looks Tantalizing, But Looks Can Be Deceptive
Syndax Pharmaceuticals struggles with competitive pressures and market skepticism despite promising drugs and strong cash position. Read more on SNDX here.
Le Lézard6d
Cytonics Announces Successful Completion of Phase 1 Study for First Nine Patients in CYT-108 Clinical Trial
Cytonics Corporation, a private biotechnology company developing cutting-edge biologic therapies for musculoskeletal conditions, today announced that the first nine patients in its Phase 1 clinical ...
Rigel's fostamatinib enters Phase 1 trial for sickle cell treatment
This article is based on a press release statement from Rigel Pharmaceuticals (NASDAQ:RIGL), Inc. The company maintains a healthy financial position with a current ratio of 1.96 and operates with a ...
Daily Mail5d
Trump orders 'blackout' at CDC, FDA, NIH as health agencies prepare for MAGA bloodbath
The CDC, FDA, HHS and NIH have all been told to pause external communications, including publishing scientific reports, updating websites or issuing health advisories. The directive came without ...
Becker's Hospital Review12d
NIH director steps down
She will leave the agency Jan. 17, three days before the inauguration of President-elect Donald Trump, according to a Jan. 14 NIH statement. In the statement, Dr. Bertagnolli reflected on the ...
CNN26d
As pace and severity of human H5N1 cases accelerate, NIH leaders call for more action on bird flu
Most human cases of bird flu in North America have been mild, a fact that’s underscored by a new study of the first 46 confirmed human H5N1 infections in the United States this year. But the ...
News Medical on MSN5d
Sudden Infant Death Syndrome biomarker discovery could identify babies at risk
New University of Virginia School of Medicine research revealing the fingerprints of Sudden Infant Death Syndrome (SIDS) ...
Science Daily11d
Red light linked to lowered risk of blood clots
Humans and mice exposed to long-wavelength red light had lower rates of blood clots that can cause heart attacks, lung damage and strokes, according to research led by surgeon-scientists.
The New England Journal of Medicine5d
Platelet-Targeted Gene Therapy for Hemophilia A with Inhibitor History
Factor VIII gene was introduced into hematopoietic stem cells in men with hemophilia. The annualized bleeding rate went from 10 to 0. No worrisome gene integrations were seen. The content of this ...